AMLX   $5.26  1.35% Market Closed After Close 5.23 -0.57%

Amylyx Pharmaceuticals Inc

EMA (20): 2024-11-14 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

EMA (50): 2024-09-05 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2024-10-04 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: entrance to the overbought zone.

MACD: Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: exit from the oversold zone.

Trend Type down and flat
Power slow
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield 2.87%
EMA (20) date of signal Nov. 14, 2024, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 135.37%
EMA (50) date of signal Sept. 5, 2024, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 65.29%
EMA (100) date of signal Oct. 4, 2024, 3 a.m.
RSI Signals bullish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Nov. 21, 2024, 3 a.m.
MACD Signals bearish reversal
MACD Yield -8.63%
MACD date of signal Nov. 13, 2024, 3 a.m.
Stochastic Signals bullish reversal
Stochastic Yield -0.57%
Stochastic date of signal Nov. 19, 2024, 3 a.m.
Updated Nov. 22, 2024, 11 p.m.